Cargando…

Epidémiologie et stratégies de riposte contre la COVID-19: l´expérience sénégalaise de 2020 à 2021

INTRODUCTION: in response to the SARS-CoV-2 pandemic that reached Senegal in March 2020, the country has put in place several strategies to contain its spread. The purpose of this study was to describe the epidemiology and the strategies adopted. MÉTHODS: we conducted a descriptive cross-sectional s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ndiaye, Mbouna, Sow, Kalidou Djibril, Ly, Alioune Badara, Diop, Boly, Ba, Mady, Faye, Adama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024565/
https://www.ncbi.nlm.nih.gov/pubmed/36942135
http://dx.doi.org/10.11604/pamj.2022.43.204.38290
_version_ 1784909135707373568
author Ndiaye, Mbouna
Sow, Kalidou Djibril
Ly, Alioune Badara
Diop, Boly
Ba, Mady
Faye, Adama
author_facet Ndiaye, Mbouna
Sow, Kalidou Djibril
Ly, Alioune Badara
Diop, Boly
Ba, Mady
Faye, Adama
author_sort Ndiaye, Mbouna
collection PubMed
description INTRODUCTION: in response to the SARS-CoV-2 pandemic that reached Senegal in March 2020, the country has put in place several strategies to contain its spread. The purpose of this study was to describe the epidemiology and the strategies adopted. MÉTHODS: we conducted a descriptive cross-sectional study of confirmed cases of COVID-19 using RT-PCR test in Senegal from March 2, 2020 to September 30, 2021. Data were collected through a literature review and analyzed with R and QGIS software. Proportions and means with standard deviation were calculated. RESULTS: Senegal has recorded a total of 73,782 confirmed cases and 1,859 deaths from SARS-CoV-2. The temporal evolution was marked by three epidemic waves. The epidemic was concentrated in high-density areas such as Dakar (48,656 cases or 66%), in men (sex-ratio 1:13) and in the age group 25-34 years (16.527 cases or 22.4%). The average age of patients was 43 ± 18 years; the national cumulative incidence was 428 per 100,000 population and the overall case fatality rate was 2.5% (1,859/73,782). Some strategies have been implemented, including staff training, restrictive measures, home-based case management and vaccination. Nine point two percent (840,154/9,128,453) of the target population received 2 doses of vaccine. CONCLUSION: the epidemic was spread more widely within some population groups. We recommend strengthening preventive measures in high-density cities and mobilizing community networks to encourage immunization.
format Online
Article
Text
id pubmed-10024565
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-100245652023-03-19 Epidémiologie et stratégies de riposte contre la COVID-19: l´expérience sénégalaise de 2020 à 2021 Ndiaye, Mbouna Sow, Kalidou Djibril Ly, Alioune Badara Diop, Boly Ba, Mady Faye, Adama Pan Afr Med J Research INTRODUCTION: in response to the SARS-CoV-2 pandemic that reached Senegal in March 2020, the country has put in place several strategies to contain its spread. The purpose of this study was to describe the epidemiology and the strategies adopted. MÉTHODS: we conducted a descriptive cross-sectional study of confirmed cases of COVID-19 using RT-PCR test in Senegal from March 2, 2020 to September 30, 2021. Data were collected through a literature review and analyzed with R and QGIS software. Proportions and means with standard deviation were calculated. RESULTS: Senegal has recorded a total of 73,782 confirmed cases and 1,859 deaths from SARS-CoV-2. The temporal evolution was marked by three epidemic waves. The epidemic was concentrated in high-density areas such as Dakar (48,656 cases or 66%), in men (sex-ratio 1:13) and in the age group 25-34 years (16.527 cases or 22.4%). The average age of patients was 43 ± 18 years; the national cumulative incidence was 428 per 100,000 population and the overall case fatality rate was 2.5% (1,859/73,782). Some strategies have been implemented, including staff training, restrictive measures, home-based case management and vaccination. Nine point two percent (840,154/9,128,453) of the target population received 2 doses of vaccine. CONCLUSION: the epidemic was spread more widely within some population groups. We recommend strengthening preventive measures in high-density cities and mobilizing community networks to encourage immunization. The African Field Epidemiology Network 2022-12-23 /pmc/articles/PMC10024565/ /pubmed/36942135 http://dx.doi.org/10.11604/pamj.2022.43.204.38290 Text en Copyright: Mbouna Ndiaye et al. https://creativecommons.org/licenses/by/4.0/The Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Ndiaye, Mbouna
Sow, Kalidou Djibril
Ly, Alioune Badara
Diop, Boly
Ba, Mady
Faye, Adama
Epidémiologie et stratégies de riposte contre la COVID-19: l´expérience sénégalaise de 2020 à 2021
title Epidémiologie et stratégies de riposte contre la COVID-19: l´expérience sénégalaise de 2020 à 2021
title_full Epidémiologie et stratégies de riposte contre la COVID-19: l´expérience sénégalaise de 2020 à 2021
title_fullStr Epidémiologie et stratégies de riposte contre la COVID-19: l´expérience sénégalaise de 2020 à 2021
title_full_unstemmed Epidémiologie et stratégies de riposte contre la COVID-19: l´expérience sénégalaise de 2020 à 2021
title_short Epidémiologie et stratégies de riposte contre la COVID-19: l´expérience sénégalaise de 2020 à 2021
title_sort epidémiologie et stratégies de riposte contre la covid-19: l´expérience sénégalaise de 2020 à 2021
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024565/
https://www.ncbi.nlm.nih.gov/pubmed/36942135
http://dx.doi.org/10.11604/pamj.2022.43.204.38290
work_keys_str_mv AT ndiayembouna epidemiologieetstrategiesderipostecontrelacovid19lexperiencesenegalaisede2020a2021
AT sowkalidoudjibril epidemiologieetstrategiesderipostecontrelacovid19lexperiencesenegalaisede2020a2021
AT lyaliounebadara epidemiologieetstrategiesderipostecontrelacovid19lexperiencesenegalaisede2020a2021
AT diopboly epidemiologieetstrategiesderipostecontrelacovid19lexperiencesenegalaisede2020a2021
AT bamady epidemiologieetstrategiesderipostecontrelacovid19lexperiencesenegalaisede2020a2021
AT fayeadama epidemiologieetstrategiesderipostecontrelacovid19lexperiencesenegalaisede2020a2021